GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in interests in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned Executive Director on 8 May 2015:
|
GSK Deferred Annual Bonus Plan
|
S Dingemans
|
Exercise of a nil priced option over 34,220 shares and 4,620 shares granted on 9 March 2012, both of which vested on 9 March 2015 under the GlaxoSmithKline Deferred Annual Bonus Plan. GlaxoSmithKline delivered the net of tax value in shares being 20,585.
|
The fair market value of an Ordinary Share at the point of exercise on 8 May 2015 was £14.72.
The Company and the above-mentioned Executive Director were advised of this transaction on 11 May 2015.
This notification relates to a transaction notified in accordance with paragraph 3.1.4R(1)(a) of the Disclosure and Transparency Rules.
V A Whyte
Company Secretary
11 May 2015